Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target?

Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191.

Authors

Emily Klann^{1

2}, Shannan Rich^{1

2}, Volker Mai^{1

2}

Affiliations

¹ Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
² Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
COVID-19*
Gastrointestinal Microbiome*
Humans
Influenza A Virus, H1N1 Subtype*
Influenza, Human*
SARS-CoV-2

Substances

Biomarkers